iShares LifePath Target Date 2055 ETF (NYSEARCA:ITDG – Get Free Report) was the target of a large decrease in short interest during the month of June. As of June 15th, there was short interest totaling 13,449 shares, a decrease of 45.7% from the May 31st total of 24,766 shares. Approximately 1.1% of the shares of the stock are sold short. Based on an average trading volume of 8,809 shares, the days-to-cover ratio is presently 1.5 days.
Institutional Investors Weigh In On iShares LifePath Target Date 2055 ETF
A hedge fund recently bought a new stake in iShares LifePath Target Date 2055 ETF stock. Citadel Advisors LLC purchased a new position in iShares LifePath Target Date 2055 ETF (NYSEARCA:ITDG – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 8,481 shares of the company’s stock, valued at approximately $315,000. Citadel Advisors LLC owned approximately 1.09% of iShares LifePath Target Date 2055 ETF at the end of the most recent reporting period.
iShares LifePath Target Date 2055 ETF Price Performance
Shares of NYSEARCA:ITDG traded down $0.21 on Wednesday, hitting $41.96. The company’s stock had a trading volume of 16,147 shares, compared to its average volume of 10,425. The company has a market capitalization of $51.19 million, a PE ratio of 20.29 and a beta of 0.89. The company has a 50-day simple moving average of $41.42 and a 200 day simple moving average of $39.48. iShares LifePath Target Date 2055 ETF has a 1 year low of $34.33 and a 1 year high of $42.55.
iShares LifePath Target Date 2055 ETF Company Profile
The iShares LifePath Target Date 2055 ETF (ITDG) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2055 ITDG was launched on Oct 17, 2023 and is issued by BlackRock.
Read More
- Five stocks we like better than iShares LifePath Target Date 2055 ETF
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for iShares LifePath Target Date 2055 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2055 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
